Search This Blog

Monday, July 20, 2026

Halozyme, Incyte sign global ENHANZE license for INCA033989 with options on two more targets

 


  • Incyte will make upfront, milestone and royalty payments to Halozyme under the collaboration and license agreement.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)